In the first clinical trial of its kind, an A.I. chatbot eased mental health symptoms among participants. The technology may ...

Breakthrough Dartmouth study crystallizes AI's capacity to curate services and spur business innovation. Ten tech readiness ...

Dartmouth's Therabot trial shows promising results for AI-assisted therapy, reducing depression symptoms by 51% and anxiety ...

The professor discussed the results of his clinical trial that evaluated the effectiveness of “Therabot,” an artificial ...

Adults showed a significant reduction in their clinical-level mental health symptoms with unrestricted access to a generative ...

The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...

The study was published in March in the journal NEJM AI. Researchers conducted a trial with 106 people who used Therabot, a smartphone app developed at Dartmouth over the past several years. It's a ...

Study finds AI chatbot significantly improve symptoms for those suffering from major depressive disorder (MDD), generalized anxiety disorder (GAD), and eating disorders in just two months.

The importance of training data suggests that the flood of companies promising therapy via AI models, many of which are not ...

The randomized clinical trial of Therabot, published in NEJM AI, found that an AI-trained therapy chatbot could play a vital role in expanding access to CBT. A New Frontier in Mental Health Care The ...

Called Therabot, the AI assistant was tested in the form of an app among participants diagnosed with serious mental health problems across the United States. “The improvements in symptoms we ...

The control group then had access to the smartphone chatbot known as Therabot from week four through to week eight. Unlike chatbots such as ChatGPT, Therabot would initiate engagement with the ...